New drug found to slow Alzheimer’s hailed as turning point
manchestereveningnews.co.ukA new drug has been hailed as a "turning point in the fight against Alzheimer’s" after it was found to slow the progression of the disease.
Donanemab was found to slow "clinical decline" by up to 35 per cent, meaning that people with the disease could still go about performing day-to-day tasks including shopping, housekeeping, managing finances and taking medication.
Alzheimer’s Research UK said that "we’re entering a new era where Alzheimer’s disease could become treatable". The Alzheimer’s Society said that treatments like donanemab could one day mean the condition could be likened to other long-term ailments such as asthma or diabetes.
The charity said new treatments including donanemab – which works by removing a protein called amyloid that builds up in the brains of people with Alzheimer’s – heralds a "new era" for Alzheimer’s disease treatments. Try MEN Premium for FREE by clicking here for no ads, fun puzzles and brilliant new features. The health spending watchdog in England is already assessing whether the drug can be used in the NHS.
Read more on manchestereveningnews.co.uk